Fennec Pharmaceuticals Inc

NASDAQ:FENC   3:59:54 PM EDT
6.71
+0.20 (+3.07%)
Products

Fennec Pharmaceuticals Announces FDA Acceptance Of New Drug Application Resubmission For Pedmark

Published: 06/22/2021 10:15 GMT
Fennec Pharmaceuticals Inc (FENC) - Fennec Pharmaceuticals Announces FDA Acceptance of New Drug Application Resubmission for Pedmark™.
Fennec Pharmaceuticals Inc - PDUFA Target Action Date Set for November 27, 2021.
Fennec Pharmaceuticals - Pedmark Granted Fast Track Designation and Breakthrough Therapy Designation by FDA.